Kazumasa Harada - Concepedia

Author

Kazumasa Harada

Tokyo Metropolitan Geriatric Hospital ORCID

Also Known As

Harada K, Harada, K., K Harada, K. HARADA, K. Harada, K.H. Harada, KOHEI HARADA, Kazumasa HARADA, Kazumasa Harada, Takayuki Abe

265

Publications

Citations

H-Index

106

Concepts

All Affiliations

Tokyo Metropolitan Geriatric Hospital The University of Tokyo Rikkyo University Shibuya University Network Tokyo Metropolitan Institute of Gerontology

About

Kazumasa Harada is an author at Tokyo Metropolitan Geriatric Hospital specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.5K
2	Engineering	9	9	162
3	Health Sciences	6	6	504
4	Public Health	3	3	68
5	Natural Sciences	2	2	35

Kazumasa Harada

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis Justin D. Pearlman, Mark G. Hibberd, Michael L. Chuang, Nature Medicine AngiogenesisVascular BiologyMagnetic Resonance MappingBiomedical EngineeringNeovascularization	1995	327
Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. Kazumasa Harada, William Grossman, M. Friedman, Journal of Clinical Investigation Cardiac MuscleHeart FailureCardiac Progenitor CellsCardiac RegenerationBiomedical Engineering	1994	305
Vascular endothelial growth factor administration in chronic myocardial ischemia Kazumasa Harada, M. Friedman, John J. López, American Journal of Physiology-Heart and Circulatory Physiology Biomedical EngineeringChronic Myocardial IschemiaAngiogenesisCardiologyAtherosclerosis	1996	241
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75) Yasuyoshi Ouchi, Junichi Sasaki, Hidenori Arai, Circulation	2019	208
Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Hitoshi Shimano, Nobuhiro Yamada, Motoya Katsuki, Proceedings of the National Academy of Sciences GeneticsLipid PeroxidationHyperlipidemiaOxidative StressMetabolic Syndrome	1992	144
Cellular Basis for the Acute Inhibitory Effects of IL-6 and TNF- on Excitation-contraction Coupling Kazuro Sugishita, Koh‐ichiro Kinugawa, Tatsuya Shimizu, Journal of Molecular and Cellular Cardiology ImmunologyCell DeathImmunologic MechanismImmunotherapyCellular Physiology	1999	103
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic Yoshiaki Tamura, Joji Ishikawa, Yoshinori Fujiwara, BMC Geriatrics	2018	102
Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial Masaharu Shinkai, Kenji Tsushima, Shingo Tanaka, Infectious Diseases and Therapy	2021	77
Association Between Prehospital Time Interval and Short-Term Outcome in Acute Heart Failure Patients Masashi Takahashi, Shun Kohsaka, Hiroaki Miyata, Journal of Cardiac Failure Heart FailureCardiovascular DiseaseMedicineMyocardial InfarctionPatient Safety	2011	65
Waon Therapy for Managing Chronic Heart Failure　– Results From a Multicenter Prospective Randomized WAON-CHF Study – Chuwa Tei, Teruhiko Imamura, Koichiro Kinugawa, Circulation Journal	2016	58

Page 1